Literature DB >> 6797774

Is the pro-adhesive activity of plasma von Willebrand factor counteracted by a physiological inhibitor of platelet adhesiveness?

M Porta, E Cagliero, E M Kohner.   

Abstract

1. Abnormal plasma levels of von Willebrand factor are accompanied by abnormal platelet function in some disease states. 2. Platelet retention in glass bead columns, platelet aggregation in vitro, beta-thromboglobulin and 6-oxo-prostaglandin F1 alpha were monitored in six normal male volunteers before and after an acute rise of von Willebrand factor, as induced by the intravenous administration of 1-deamino 8-D-arginine vasopressin (DDAVP). 3. After DDAVP a steady twofold rise of von Willebrand factor occurred. Platelet retention increased by 74% immediately after DDAVP but returned to baseline values within 60-120 min. No consistent changes of the other variables were observed. 4. These results suggest that as yet unidentified mechanism(s) inhibits the pro-adhesive activity of von Willebrand factor.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6797774     DOI: 10.1042/cs0620239

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  4 in total

Review 1.  Endothelial cell function in diabetic microangiopathy.

Authors:  M Porta; M La Selva; P Molinatti; G M Molinatti
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

2.  A study of platelet-relevant parameters in patients with diabetic microangiopathy.

Authors:  M Porta; A M Peters; S A Cousins; E Cagliero; M L FitzPatrick; E M Kohner
Journal:  Diabetologia       Date:  1983-07       Impact factor: 10.122

3.  Availability of endothelial von Willebrand factor and platelet function in diabetic patients infused with a vasopressin analogue.

Authors:  M Porta
Journal:  Diabetologia       Date:  1982-11       Impact factor: 10.122

Review 4.  The role of endothelium in the pathogenesis of diabetic microangiopathy.

Authors:  M La Selva; E Beltramo; P Passera; M Porta; G M Molinatti
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.